These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 512862)

  • 1. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of griseofulvin plain tablets in stomach-emptying controlled rabbits and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    J Pharmacobiodyn; 1984 Sep; 7(9):630-40. PubMed ID: 6527208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of griseofulvin from tablets in humans and the correlation with its dissolution rate.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A
    J Pharm Sci; 1982 Oct; 71(10):1165-9. PubMed ID: 7143217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of different brands of griseofulvin tablets and its correlation to dissolution data.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1980 Aug; 35(8):482-4. PubMed ID: 7433499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Yasuda Y; Tanioka Y
    J Pharmacobiodyn; 1984 Jan; 7(1):7-14. PubMed ID: 6726615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tamaki N; Kamimura H; Katougi Y; Omi Y
    J Pharm Sci; 1982 Oct; 71(10):1169-72. PubMed ID: 7143218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rabbits for GI drug absorption studies.
    Maeda T; Takenaka H; Yamahira Y; Noguchi T
    J Pharm Sci; 1977 Jan; 66(1):69-73. PubMed ID: 556768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS; Aboul-Einien MH
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast-dissolving microparticles fail to show improved oral bioavailability.
    Wong SM; Kellaway IW; Murdan S
    J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
    Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man.
    Bates TR; Fung HL; Lee H; Tembo AV
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):233-43. PubMed ID: 1153870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of high fat diet on GI absorption of griseofulvin tablets in man.
    Khalafalla N; Elgholmy ZA; Khalil SA
    Pharmazie; 1981 Oct; 36(10):692-3. PubMed ID: 7312923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man.
    Bates TR; Pieniaszek HJ; Sequeira JA; Rasmussen JE
    Arch Dermatol; 1977 Mar; 113(3):302-6. PubMed ID: 843096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixing-tank model for predicting dissolution rate control or oral absorption.
    Dressman JB; Fleisher D
    J Pharm Sci; 1986 Feb; 75(2):109-16. PubMed ID: 3958917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of dissolution rate and drug absorption in man.
    Katchen B
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():88-97. PubMed ID: 5316414
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.